News
Wacker and Amyris join forces to develop bio-based functional ingredients
3+ day, 16+ hour ago (568+ words) (Page 1) Wacker Chemie AG (Munich, Germany) and Amyris, Inc. (Emeryville, Calif.) announced at the in-cosmetics trade show in Paris, France, that the two companies Wacker and Amyris join forces to develop bio-based functional ingredients Wacker Chemie AG (Munich, Germany) and…...
Enhancing Quality and Accelerating the Development of Bispecific Antibodies
1+ mon, 1+ week ago (654+ words) The past few years have seen a striking upward trend in regulatory approvals and industry investment for bispecific antibodies (Bs Abs). The global Bs Ab market is predicted to grow at a CAGR of over 44% through 2030. 1 A recent article in…...
Creative Biolabs' New AI Platform Accelerates CAR-T and Antibody Humanization
1+ mon, 3+ day ago (242+ words) Creative Biolabs today announced the upgrade of its next-generation drug discovery pipeline with integrated AI-driven antibody engineering platform. SHIRLEY, NY. .. (1 of 10) Upper Bucks County: Freeze Watch from TUE 12: 00 AM EDT until TUE 9: 00 AM EDT (2 of 10) Warren County: Freeze Watch from…...
Amazon Biopharma Research Debuts With AI Agents
4+ day, 18+ hour ago (593+ words) The "Amazon Bio Discovery" research platform, launched today, does not display ads in its results or search a database, but it does have AI agentic technology and connect to some of its partners that support this project." Launched by"Amazon…...
Tsingke Launches Breakthrough "Zero-Contact" System to Protect Gene Data - Scientist Live
1+ day, 23+ hour ago (250+ words) Contact Sequences" system, an automated, on-site platform developed to reduce the risk of sequence exposure while providing a practical model for secure and efficient research and development. Across. .. The pace of biotechnology research is accelerating, leaving companies with the challenge…...
Amino Acid Cocktail Supercharges LNP Delivery for m RNA and CRISPR Therapies
1+ mon, 6+ day ago (553+ words) Lipid nanoparticles (LNPs) act as carriers for m RNA and CRISPR payloads across a wide range of therapeutic applications, from cancer to inflammatory and genetic diseases. The same delivery system used. .. Lipid nanoparticles (LNPs) act as carriers for m RNA…...
Advancing m RNA Therapeutics with Mass Photometry
1+ mon, 2+ week ago (140+ words) m RNA technologies have rapidly evolved into one of the most exciting and versatile classes of modern medicines, powering breakthroughs in vaccines and emerging therapies for metabolic, cardiovascular, .. . m RNA technologies have rapidly evolved into one of the most exciting…...
Best Practices in q PCR and d PCR Assays in Cell and Gene Therapy Development
2+ week, 3+ day ago (282+ words) Join Dr. Mikael Kubista, a pioneer of developing and standardizing real-time quantitative PCR (q PCR) and digital PCR (d PCR) assays for research and diagnostics. As a member of the American Association. .. Best Practices in q PCR and d PCR…...
3 D tumor organoids give brain tumor researchers new scientific opportunities
3+ day, 19+ hour ago (96+ words) (L to R) Qianqian Li, Ph D; Dana Farmer, Ph D; first author Justin Williams, Ph D; corresponding author Martine Roussel, Ph D, all of'St. Jude'Department of Tumor Cell Biology, and Jake Friske, Ph D, St. Jude Graduate School of Biomedical…...
New lab-grown organoids accurately mimic pediatric brain tumor biology
2+ day, 20+ hour ago (251+ words) Efforts to identify and evaluate next-generation therapeutics for pediatric brain tumors are easily stymied by the quality and availability of laboratory models for research. To address this issue, scientists at'St. Jude Children's Research Hospital developed patient-derived tumor organoids and tumor…...